Page History
The following map members from SNOMED CT to the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (© World Health organisation 1994) 2016 Version are published (or will be published) in the SNOMED CT International Edition. These maps use ICD-10 codes identified in the WHO's Emergency use ICD codes for COVID-19 disease outbreak update
| Footnote ref |
|---|
| SNOMED CT | ICD-10 | ||||
| SNOMED CT Id | SNOMED CT Fully Specified Name | ICD-10 Code | ICD-10 Term | Map Advice | Effective Time |
|---|---|---|---|---|---|
| 1119302008 | Acute disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION | 20210131 |
| 138389411000119105 | Acute bronchitis caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION | 20210131 |
| 870590002 | Acute hypoxemic respiratory failure due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
| 870589006 | Acute kidney injury due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
| 674814021000119106 | Acute respiratory distress syndrome due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
| 189486241000119100 | Asymptomatic Severe acute respiratory syndrome coronavirus 2 infection (finding) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
| 119731000146105 | Cardiomyopathy due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
| 1119304009 | Chronic post-COVID-19 syndrome (disorder) | U09.9 | Post COVID-19 condition, unspecified | 20210131 | |
| 119741000146102 | Conjunctivitis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
840539006 |
| Disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION |
| 20210131 | |||||
| 119981000146107 | Dyspnea caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
| 1240561000000108 | Encephalopathy due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
840546002 | Exposure to Severe acute respiratory syndrome coronavirus 2 (event) | Z20.8 | Contact with and exposure to other communicable |
| disease | 20200309 |
| 119751000146104 | Fever caused by Severe acute respiratory syndrome coronavirus 2 |
| (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
| 1240541000000107 | Infection of upper respiratory tract caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified |
| MAPPED FOLLOWING WHO GUIDANCE | 20210131 | ||||
| 880529761000119102 | Lower respiratory infection caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
| 866151004 | Lymphocytopenia due to Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
| 1240531000000103 | Myocarditis due to disease |
| Footnote ref | ||
|---|---|---|
|
| caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 | |
| 897036007 | Occupational exposure to Severe acute respiratory syndrome coronavirus 2 (event) | Z20.8 | Contact with and exposure to other communicable disease | 20210131 | |
| 1240521000000100 | Otitis media due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus |
POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION |
| identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 | |
| 882784691000119100 | Pneumonia caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, |
| virus identified |
| MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
| 1119303003 | Post-acute COVID-19 (disorder) | U09.9 | Post COVID-19 condition, unspecified | 20210131 | |
| 870591003 | Rhabdomyolysis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
| 870588003 | Sepsis due to disease caused by Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
| 1240581000000104 | Severe acute respiratory syndrome coronavirus 2 detected (finding) | U07.1 | COVID-19, virus identified | 20200731 | |
| 866152006 | Thrombocytopenia due to Severe acute respiratory syndrome coronavirus 2 (disorder) | U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
| 1017214008 | Viremia |
| Concept | ||
|---|---|---|
|
| caused by Severe acute respiratory syndrome coronavirus 2 |
| (disorder) |
| U07.1 | COVID-19, virus identified | MAPPED FOLLOWING WHO GUIDANCE | 20210131 |
| Footnote block |
|---|
|
Overview
Content Tools
Apps